Self-Control Trial to Evaluate the Remission Rate and Safety in Newly Diagnosed Type 2 Diabetes Patients After Short-Term Intensive Insulin Aspart and Insulin NPH Treatment.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin aspart; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Mar 2016 Biomarkers information updated
- 06 Oct 2009 Actual patient number changed from 220 to 33 as reported by ClinicalTrials.gov.
- 12 May 2009 Actual patient number changed from 113 to 220 as reported by ClinicalTrials.gov.